Skip to Content

Rozlytrek Prices, Coupons and Patient Assistance Programs

Rozlytrek (entrectinib) is a member of the multikinase inhibitors drug class and is commonly used for Non-Small Cell Lung Cancer and Solid Tumors.

Rozlytrek Prices

This Rozlytrek price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Rozlytrek oral capsule 100 mg is around $5,856 for a supply of 30 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Rozlytrek is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Rozlytrek availability.

Oral Capsule

100 mg Rozlytrek oral capsule
from $5,855.90 for 30 capsule
Quantity Per unit Price
30 $195.20 $5,855.90

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

200 mg Rozlytrek oral capsule
from $17,548.70 for 90 capsule
Quantity Per unit Price
90 $194.99 $17,548.70

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Rozlytrek Coupons and Rebates

Rozlytrek offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Rozlytrek BioOncology Co-Pay Assistance Program: Eligible commercially insured patients may pay as little as $5 per co-pay/co-insurance with savings of up to $25,000 per year; for additional information contact the program at 855-692-6729.

Applies to:Rozlytrek
Number of uses:Per prescription until program expires

Patient Assistance Programs for Rozlytrek

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Rozlytrek (entrectinib) Capsule

Provider: Genentech Access Solutions BioOncology

Elligibility requirements:

  1. Determined case by case
  2. Based on FPL
  3. Varies
  4. Must be treated by US licensed healthcare provider
  5. Call for most recent medications as the list is subject to change. Eligibility determined on a case-by-case basis. Contact program for details.

Applicable drugs:

  • Rozlytrek (entrectinib) Capsule

Provider: Genentech Patient Foundation

Elligibility requirements:

  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Income Guidelines published on Program Website
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Rozlytrek (entrectinib) Capsule
Hide